April 1, 2007
Wyeth's Profit Likely Rising as Fen-Phen Payments Nearing End
Article in the Washington Post -- Wyeth shares could rise more than 20 pct: Barron's, from Reuters. Here's an excerpt: "The newspaper said Wyeth may also be near the end of incurring costs for its discontinued fen-phen diet drug, following a nationwide settlement and $21 billion of charges."
TrackBack URL for this entry:
Listed below are links to weblogs that reference Wyeth's Profit Likely Rising as Fen-Phen Payments Nearing End: